Literature DB >> 9873734

Acceptor substrate-based selective inhibition of galactosyltransferases.

S J Chung1, S Takayama, C H Wong.   

Abstract

This paper describes the discovery of glycosyl acceptor analogs as potent and selective inhibitors of alpha-1,3- and beta-1,4-galactosyltransferases. Incorporation of an appropriate aromatic group to the aglycon position of the enzyme's acceptors results in a strong inhibition, representing the first and most potent small uncharged molecules as selective inhibitors of these two enzymes and thus providing a new strategy for the development of selective glycosyltransferase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9873734     DOI: 10.1016/s0960-894x(98)00618-0

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  5-thiomannosides block the biosynthesis of dolichol-linked oligosaccharides and mimic class I congenital disorders of glycosylation.

Authors:  Wesley F Zandberg; Ningguo Gao; Jayakanthan Kumarasamy; Mark A Lehrman; Nabil G Seidah; B Mario Pinto
Journal:  Chembiochem       Date:  2012-01-19       Impact factor: 3.164

2.  UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme.

Authors:  Inka Brockhausen; Melinda Benn; Shridhar Bhat; Sandra Marone; John G Riley; Pedro Montoya-Peleaz; Jason Z Vlahakis; Hans Paulsen; John S Schutzbach; Walter A Szarek
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

3.  Deoxygenated disaccharide analogs as specific inhibitors of beta1-4-galactosyltransferase 1 and selectin-mediated tumor metastasis.

Authors:  Jillian R Brown; Feng Yang; Anjana Sinha; Boopathy Ramakrishnan; Yitzhak Tor; Pradman K Qasba; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-12-23       Impact factor: 5.157

Review 4.  Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.

Authors:  Andréia Vasconcelos-Dos-Santos; Isadora A Oliveira; Miguel Clodomiro Lucena; Natalia Rodrigues Mantuano; Stephen A Whelan; Wagner Barbosa Dias; Adriane Regina Todeschini
Journal:  Front Oncol       Date:  2015-06-25       Impact factor: 6.244

5.  An acceptor analogue of β-1,4-galactosyltransferase: Substrate, inhibitor, or both?

Authors:  Jingqian Jiang; Gerd K Wagner
Journal:  Carbohydr Res       Date:  2017-08-31       Impact factor: 2.104

6.  Synthesis and Preliminary Evaluation of Biological Activity of Glycoconjugates Analogues of Acyclic Uridine Derivatives.

Authors:  Roman Komor; Gabriela Pastuch-Gawolek; Ewelina Krol; Wieslaw Szeja
Journal:  Molecules       Date:  2018-08-13       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.